Abstract
Variability in an individual's clearance of theophylline is an important consideration when estimating bioavailability. A method is described for compensating for this problem, using the serum concentration of theophylline and urinary excretion data on its major metabolites to make an estimation of the clearance after oral administration using the intravenous dose as reference. The method is particularly useful for assessing the bioavailability of slow-release theophylline preparations.
Similar content being viewed by others
References
J. W. Jenne, M. S. Wyze, B. S. Rood, and F. M. MacDonald. Pharmacokinetics of theophylline: Application to adjustment of the clinical dose of aminophylline.Clin. Pharmacol. Ther. 13:349–360 (1972).
E. Ginchansky and M. Weinberger. Relationship of theophylline clearance to oral dosage in children with chronic asthma.J. Pediatr. 91:655–660 (1977).
P. D. Walson, R. C. Strunk, and L. M. Taussig. Intrapatient variability in theophylline kinetics.J. Pediatr. 91:321–324 (1977).
L. Patric, A. Kalisker, and T. D. Bell. Variation in theophylline clearance rate with time in chronic childhood asthma.J. Allergy Clin. Immunol. 59:440–444 (1977).
J. D. Arnold, G. N. Hill, and L. N. Sansom. A comparison of theophylline in asthmatic children in the acute episode and in remission.Eur. J. Clin. Pharmacol. 20: 443–447 (1981).
R. A. Upton, J. F. Thiercelin, T. W. Guentert, S. M. Wallace, J. R. Powell, L. Sansom, and S. Riegelman. Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults.J. Pharmacokin. Biopharm. 10:123–134 (1982).
P. A. Mitenko and R. I. Ogilvie. Bioavailability and efficacy of a sustained-release theophyl-line tablet.Clin. Pharmacol. Ther. 16:720–726 (1974).
D. L. Spangler, D. D. Kalof, F. L. Bloom, and H. J. Wittig. Theophylline bioavailability following oral administration of six sustained-release preparations.Ann. Allergy 40:6–11 (1978).
M. Weinberger, L. Hendeles, and L. Bighley. The relation of product formulation to absorption of oral theophylline.N. Engl. J. Med. 299:852–857 (1978).
J. H. G. Jonkman, D. D. S. Tang, R. A. Upton, and S. Riegelman. Measurement of excretion characteristics of theophylline and its major metabolites.Eur. J. Clin. Pharmacol. 20:435–441 (1981).
T. J. Haley. Metabolism and pharmacokinetics of theophylline in human neonates, children, and adults.Drug Metab. Rev. 14:295–335 (1983).
T. J. Monks, C. H. Caldwell, and R. L. Smith. Influence of methylxanthine-containing foods on theophylline metabolism and kinetics.Clin. Pharmacol. Ther. 26:514–524 (1979).
K. T. Muir, J. H. G. Jonkman, D. Tang, M. Kunitani, and S. Riegeiman. Simultaneous determination of theophylline and its major metabolites in urine by reversed-phase ion pair high-performance liquid chromatography.J. Chromatogr. 221:85–95 (1980).
D. D. Tang-Liu, R. L. Williams, and S. Riegeiman. Non-linear theophylline elimination.Clin. Pharmacol. Ther. 31:358–369 (1982).
L. Hendeles, M. Weinberger, and L. Bighley. Absolute bioavailability of oral theophylline.Am. J. Hosp. Pharm. 34:525–527 (1977).
J. H. G. Jonkman, W. C. Berg, R. Schoenmaker, R. A. deZeeuw, J. E. Greving, and N. G. M. Orie. Disposition and clinical pharmacokinetics of microcrystalline theophylline.Eur. J. Clin. Pharmacol. 17:379–384 (1980).
R. A. Upton, L. Sansom, T. W. Guentert, J. R. Powell, J. F. Thiercelin, V. P. Shah, P. E. Coates, and S. Riegeiman. Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria.J. Pharmacokin. Biopharm. 8:229–242 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kasuya, Y., Ohno, T., Kubota, N. et al. New method for bioavailability assessment of slow-release preparations of theophylline. Journal of Pharmacokinetics and Biopharmaceutics 13, 571–587 (1985). https://doi.org/10.1007/BF01058902
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01058902